REQUEST A DEMO
Total
USD $0.00
Search more companies

Hepharm Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Other Chemical Product and Preparation Manufacturing | Other Miscellaneous Durable Goods Merchant Wholesalers | Miscellaneous Store Retailers | Other Direct Selling Establishments | Other Information Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Hepharm Sp. z o.o. Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Hepharm Sp. z o.o. is based in Poland. The head office is in Pulawy. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on December 13, 2016. 1 (2017) employees currently work for Hepharm Sp. z o.o.. The latest financial highlights indicate a net sales revenue drop of 83.6% in 2023. Its’ total assets recorded a negative growth of 39.79%. The net profit margin of Hepharm Sp. z o.o. decreased by 1806.19% in 2023.

Headquarters
Ul. Marsz. Jozefa Pilsudskiego 57/1/2
Pulawy; Lubelskie; Postal Code: 24-100

Contact Details: Purchase the Hepharm Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Hepharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Hepharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Hepharm Sp. z o.o. report to view the information.
Incorporation Date:
December 13, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
98%
Company Performance
Financial values in the chart are available after Hepharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-83.6%
Total operating revenue
-83.6%
Operating profit (EBIT)
-6.34%
EBITDA
-19.21%
Net Profit (Loss) for the Period
-6.34%
Total assets
-39.79%
Total equity
N/A
Operating Profit Margin (ROS)
-1806.19%
Net Profit Margin
-1806.19%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?